ANDOVER, Mass., Oct. 23, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative, mobile pulmonary function testing (PFT) technology is donating EasyOne Plus® devices for an October 27 free screening during Austin Lung Health Day. Nearly one in ten Austin, Texas residents have been diagnosed with chronic obstructive pulmonary disease (COPD) and the same number may be undiagnosed, based on national averages. COPD is the 3rd leading cause of death in the U.S.
The event is hosted by the American College of Chest Physicians (CHEST) and is taking place at Barton Creek Square from 11:00 am to 12:30 pm. Each year, CHEST provides free lung health screenings in the community hosting its annual meeting.
“A recent study published in the journal CHEST noted that medical costs in 2010 attributable to COPD were approximately $32.1 billion dollars, a number expected to rise to $50 billion by 2020,” said Joy Tobin, ndd’s Director of Marketing. “We make these donations to help educate about the prevalence of COPD, a disease that kills more women each year than breast cancer and diabetes combined. Many people remain undiagnosed, and a simple breathing test completed in minutes is among the most effective ways to diagnose this deadly but often treatable disease.”
Used for diagnosis of breathing capacity by NASA, the CDC’s National Institute for Occupational Safety and Health, and in National Institutes of Health (NIH) and other clinical trials, ndd’s EasyOne Plus is the world’s leading spirometry device. Its accurate ultrasonic technology eliminates problems associated with traditional methods of breathing flow measurement. Testing can be quickly and conveniently performed in clinics, doctors’ offices, research facilities or at the patient bedside.
About ndd Medical Technologies Inc.
With 40 percent of the U.S. spirometry market share, ndd Medical Technologies offers innovative, easy-to-use pulmonary function testing instruments that help clinicians diagnose lung disease with greater precision for optimal treatment. Its EasyOne® and EasyOne Pro portable instruments take up just 12 inches of space to take lung function testing wherever it is needed, measuring DLCO, FRC, LCI and FVC. ndd’s patented Ultrasonic TrueFlow technology, which requires no calibration, eliminates problems associated with traditional methods of flow measurement, making testing fast, reliable and error free. To learn more, visit www.nddmed.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/easyone-plus-mobile-pulmonary-testing-device-to-screen-for-copd-at-austin-lung-health-day-october-27-763806804.html
SOURCE ndd Medical Technologies
Help employers find you! Check out all the jobs and post your resume.
